We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
MSE.PA

Price
63.88
Stock movement down
-0.51 (-0.79%)
Company name
Amundi EURO STOXX 50 II UCITS ETF Acc
Exchange
(PA
,
Currency
EUR
)
Market cap
-
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
23.08%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-11-14

DIVIDENDS

MSE.PA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open64.60
Daily high64.70
Daily low63.87
Daily Volume50K
All-time high64.39
1y analyst estimate-
Beta1.07
EPS (TTM)-
Dividend per share0.00
Ex-div date9 Dec 2020
Next earnings date-

Downside potential

Loading...
Downside potential data
MSE.PAS&P500
Current price drop from All-time high-0.79%-2.23%
Highest price drop-16.40%-19.00%
Date of highest drop9 Apr 20258 Apr 2025
Avg drop from high-2.39%-2.71%
Avg time to new high8 days5 days
Max time to new high68 days89 days
COMPANY DETAILS
MSE.PA (Amundi EURO STOXX 50 II UCITS ETF Acc) company logo
Marketcap
-
Marketcap category
Description
The Lyxor EURO STOXX 50 (DR) UCITS ETF is a UCITS compliant exchange traded fund that aims to track the benchmark index EURO STOXX 50 Net Return EUR, offsetting the impact of daily variations of the index local currency vs. the USD. The USD-hedged share class offers the simplicity of a daily currency hedge mechanism that is embedded in the investment product, representing an efficient solution to manage the foreign-exchange risk.The EURO STOXX 50 Net Return EUR is Europe's leading Blue-chip index for the Eurozone providing a Blue-chip representation of supersector leaders in the Eurozone from 50 stocks and over 12 Eurozone countries. It captures approximately 60% of the free float market capitalisation of the EURO STOXX Total Market Index (TMI), which in turn covers approximately 95% of the free float market capitalisation of the represented countries. More information on www.stoxx.com.
Employees
Website
Investor relations
-
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Thinking about what to do with your GL Events shares? Whether you are sizing up an entry point or reassessing your position after a strong rally, now is a great time to take stock of what is really ha...
September 9, 2025
If you are weighing your next move with Banca IFIS, you are not alone. After all, the stock has served up a mix of intrigue and promise this year, catching plenty of attention across the financial lan...
September 9, 2025
The cider brand has added a high-contrast NaviLens QR code to its cans.
September 9, 2025
BioReference health, JPMorgan Chase and an Italian fashion retailer are making the job cuts amid market uncertainty
September 9, 2025
Temenos also the winner for Bank Deposit Transformation with Credem and listed in the 2025 IDC FinTech Rankings Top 25GRAND-LANCY, Switzerland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), ...
September 9, 2025
The Management Board of Artea Bankas has approved changes to the management and organizational structure. The Management Board has received a notice from board member Mindaugas Rudys regarding his res...
September 9, 2025
Novartis agreed to buy Tourmaline Bio in a roughly $1.4 billion-dollar deal that boosts its cardiovascular drug pipeline with access to the targeted therapy drug pacibekitug. The Swiss pharmaceuti...
September 9, 2025
Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmali...
September 9, 2025